Navigation Links
RxAlly Announces Addition Of Experienced Corporate Counsel Tom O'Grady To The Company's Leadership Team

LEESBURG, Va., July 16, 2012 /PRNewswire/ -- RxAlly, a first-of-its-kind alliance of more than 22,000 pharmacies nationwide, announced today the addition of Tom O'Grady to the company's leadership team.  Mr. O'Grady will serve as General Counsel and Executive Vice President of Corporate Development.  He brings more than 30 years of corporate and transactional law experience to his role as General Counsel. In the Corporate Development role, Mr. O'Grady will be structuring business relationships between RxAlly and the companies and businesses that RxAlly will be working with as it continues to align pharmacies and pharmacists, the patients they serve, and the payer community. 

Mr. O'Grady joins RxAlly from McGuireWoods LLP where he focused on transactional law for health care and other technology enabled companies.  Mr. O'Grady's experience included  mergers and acquisitions and equity and debt financing, as well as a variety of licensing, intellectual property and outsourcing transactions in his 26 years with the firm.  Prior to joining McGuireWoods LLP, he practiced in South Africa, where he became a partner in Bowman Gilfillan - one of South Africa's largest law firms. He then spent a year at Shearman & Sterling, a Wall Street law firm, before joining McGuireWoods LLP in 1985. Mr. O'Grady taught a course in strategic alliances in a graduate program as an Adjunct Professor of Law at the University of Maryland, University College, from 1991-1995.

Mr. O'Grady was recognized as one of Virginia's "Legal Elite" by Virginia Business in 2010 and named a Washington, D.C. and Virginia "Super Lawyer" in 2007. 

"RxAlly is adding an invaluable asset in Tom O'Grady," said Bruce Roberts, CEO of RxAlly. "His work in helping to establish RxAlly as our external General Counsel was invaluable.  His experience in structuring transactions to achieve aligned business goals is going to be important to us at RxAlly as we focus on how America's pharmacies will deliver better health to patients, aligning the interests of patients, payers and providers." 

"I am excited to continue working with the brilliant people leading this forward-thinking and revolutionary company," stated Tom, O'Grady, General Counsel and Executive Vice President of Corporate Development. "I am thrilled to have the opportunity to work with the RxAlly team in an internal capacity and pursue our mission of aligning the components of the health care team to better serve patients."

RxAlly is a performance network of aligned pharmacies, united to help patients achieve better health through personalized pharmacist care while reducing costs.  The company was developed to provide a new solution to the critical issues of providing additional access to care and ensuring effective health care spending at a time when prescription medicine misuse is associated with $290 billion in annual costs.

For more information, please visit:, on Facebook, or Twitter.
For media inquiries, please contact: 5W Public Relations.

About RxAlly
With more than 22,000 member pharmacies nationwide, RxAlly has brought together the largest national network of pharmacies to improve health and lower costs. The RxAlly Performance Network of community pharmacies aims to improve health through personalized pharmacist care, clinical research and evidence-based clinical practices, and an interoperable technology platform. By advancing the role of pharmacists, RxAlly is facilitating new solutions as it leads an innovative approach to health care that aligns the interests of patients, pharmacists and payers. For more information, please visit us at:, Facebook or Twitter.

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RxAlly Opens Its Doors In Leesburg, Virginia
2. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
3. Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
4. Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
5. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
6. FDAnews announces Fourth Annual Supplier Quality Congress
7. Ampio Pharmaceuticals Announces Proposed Public Offering
8. Sono-Tek Announces First Quarter Results
9. iMedX Announces Acquisition of Electronic Medical Transcription Services, Inc.
10. MDHI Enhances Service Offerings with New Options for Customers of Americas Largest Warehouse Club Chain - Announces New Extended Concierge Services
11. BioElectronics Corporation Announces Initiative for UK and German Markets
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):